STOCK TITAN

Celestica SEC Filings

CLS NYSE

Welcome to our dedicated page for Celestica SEC filings (Ticker: CLS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Celestica Inc. (CLS) files a range of documents with the U.S. Securities and Exchange Commission that provide detailed insight into its operations, governance and financial performance. As an Ontario, Canada corporation with common shares listed on the New York Stock Exchange, Celestica submits reports under the Exchange Act, including current reports on Form 8-K that disclose material events.

Recent Form 8-K filings illustrate the types of information investors can expect. Celestica has reported quarterly financial results and related conference calls, furnished press releases as exhibits, and described its guidance and outlook for revenue, adjusted operating margin, adjusted EPS and non-GAAP free cash flow. Other 8-Ks detail corporate actions such as the launch and acceptance of a normal course issuer bid on the Toronto Stock Exchange to repurchase a portion of its public float, with information on the maximum number of shares, timing and cancellation of repurchased shares.

The company’s filings also cover governance and Board matters. Examples include the appointment of new independent directors, committee assignments, and planned transitions such as the resignation of a director and the designation of a new Audit Committee Chair. These disclosures provide transparency into Celestica’s oversight structure and the experience of its Board members.

Through this SEC filings page on Stock Titan, users can access Celestica’s regulatory documents as they are made available on EDGAR. AI-powered summaries help explain key points from lengthy filings, including financial results, segment commentary for Advanced Technology Solutions (ATS) and Connectivity & Cloud Solutions (CCS), capital allocation decisions like issuer bids, and changes in corporate governance. Investors can also review insider and executive-related disclosures contained in applicable forms to better understand leadership and oversight at Celestica.

Rhea-AI Summary

Michael Max Wilson, a director of Celestica Inc. (CLS), reported multiple awards and acquisitions on 06/30/2025. The Form 4 shows a direct acquisition of 5,890 common shares (transaction code M) at $0, increasing his direct beneficial ownership to 13,391 shares. The filing also reports vesting/awards of restricted share units (RSUs) totaling 5,890 RSUs across grants from 2022–2024 and 671 director share units granted/recorded, with underlying common-share equivalents and post-transaction holdings listed for each tranche.

The RSU grants are subject to time-based vesting schedules (one-third annually) as described for grants dated June 30 of 2022, 2023 and 2024. The Form 4 was signed by an attorney-in-fact, Tracy Connelly McGilley, on 07/01/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Michael Max Wilson, a director of Celestica Inc. (CLS), reported transactions dated 03/31/2025 on Form 4. The filing shows an acquisition of 5,717 common shares (transaction code M) resulting in 7,501 common shares beneficially owned directly after the reported non-derivative transaction. The filing also records multiple equity award movements: RSU grants or vesting events of 2,517, 2,440, and 760 restricted share units (RSUs) and an acquisition of 1,300 deferred share units (DSUs). The explanatory notes clarify each RSU and DSU represents a contingent right to receive one common share or cash equivalent under specified conditions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Insider sale and filing correction at Celestica (CLS). The Form 4 shows director Michael Max Wilson sold 25,000 common shares on 01/06/2025 at a weighted average price of $98.73 per share (price converted from CAD). After the disposition the report shows 1,784 shares beneficially owned directly. The filing also corrects prior reporting by including 9,117 shares that were omitted from a Form 3 filed 12/19/2024. The transaction was signed by an attorney-in-fact on 01/08/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Michael Max Wilson, a director of Celestica Inc. (CLS), reported multiple equity award transactions on Form 4 dated 12/31/2024. The filing shows an acquisition of 6,697 common shares (code M) resulting in 17,667 shares beneficially owned after the transaction. The report also lists several restricted share unit (RSU) transactions: purchases/acquisitions of 2,795, 2,735, 1,167, and 1,092 RSUs on 12/31/2024, with corresponding beneficial ownership counts shown as 0, 2,736, 2,333, and 1,092 common shares respectively. The explanatory notes confirm the RSUs were annual grants from 2021 through 2024 and vest one-third annually over three years.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Michael Max Wilson, a director of Celestica Inc. (CLS), filed an initial Form 3 reporting ownership of 10,970 common shares directly and multiple equity award units. The filing lists 283,131 deferred share units convertible to common shares or cash on departure and a series of restricted share units granted between 2021 and 2024 totaling reported award amounts by grant: 8,386; 7,550; 9,448; 10,920; 8,207; 7,318; 6,437; 4,042; 3,500; 2,280; 1,787; 2,006, each with vesting schedules described in the filing.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Whale Rock Capital Management LLC and Alexander Sacerdote report shared beneficial ownership of 4,639,115 common shares of Celestica Inc., representing 4.03% of the outstanding Subordinate Voting Shares based on 114,991,980 shares outstanding. The filing states Whale Rock acts as investment manager for limited partnerships that own the securities, and Mr. Sacerdote is Whale Rock's managing member; both may therefore be deemed to share voting and dispositive power over the reported shares. The report shows no sole voting or dispositive power—all authority is shared. The filing also includes a joint filing statement acknowledging shared responsibility for amendments and disclosures.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Celestica Inc. (NYSE: CLS) filed a Form 8-K disclosing that its Board appointed Chris Colpitts as an independent director effective 28 July 2025. He immediately joins the Audit, Human Resources & Compensation, and Nominating & Corporate Governance Committees and will be paid under Celestica’s standard director fee schedule.

Colpitts offers 20 years of technology, media & telecommunications deal-making experience, having led global TMT investment-banking teams at Deutsche Bank and Lehman Brothers and served as US Head of TMT at CVC Capital Partners. He is currently Founder of Granite Peak Capital Group. The Board expects his strategic-transaction background to support the company’s growth initiatives.

The filing states there are no related-party transactions or special arrangements tied to his selection. Exhibit 99.1 contains the 30 July 2025 press release announcing the appointment; no other material events or financial data were reported.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.2%
Tags
current report
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
16.51%
Tags
quarterly report

FAQ

What is the current stock price of Celestica (CLS)?

The current stock price of Celestica (CLS) is $303.09 as of January 23, 2026.

What is the market cap of Celestica (CLS)?

The market cap of Celestica (CLS) is approximately 33.5B.
Celestica

NYSE:CLS

CLS Rankings

CLS Stock Data

33.47B
114.22M
0.52%
75.82%
4.35%
Electronic Components
Printed Circuit Boards
Link
Canada
TORONTO

CLS RSS Feed